15/10/02说明:此前论坛服务器频繁出错,现已更换服务器。今后论坛继续数据库备份,不备份上传附件。

肝胆相照论坛

 

 

肝胆相照论坛 论坛 肝癌,肝移植 乙型肝炎病毒相关性肝细胞癌年轻患者行根治性切除术的预 ...
查看: 544|回复: 2
go

[其他] 乙型肝炎病毒相关性肝细胞癌年轻患者行根治性切除术的预 [复制链接]

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30441 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

1
发表于 2020-8-1 20:01 |只看该作者 |倒序浏览 |打印
Prognosis factors of young patients undergoing curative resection for hepatitis B virus-related hepatocellular carcinoma: A multicenter study
Zeng J, Lin K, Liu H, et al
Cancer Management and Research|August 1, 2020

In view of the controversies concerning the prognosis of young and older patients with hepatocellular carcinoma (HCC), researchers sought to compare young (age ≤ 40 years) vs older patients (aged > 40 years) with hepatitis B virus (HBV)-related HCC in terms of their clinicopathological features and prognosis after curative resection. Among 4,504 included patients with HBV-related HCC who underwent curative resection, the young group comprised 699 patients and older group comprised 3,805 patients. Young patients vs older patients exhibited better liver function, more aggressive tumor characteristics, and worse prognosis. Poor OS and RFS were observed in young patients in correlation with a tumor size of ≥ 5 cm and macrovascular invasion. If more frequent surveillance could detect the tumors at the early stage, long-term survival can be expected in the young patients.

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30441 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

2
发表于 2020-8-1 20:01 |只看该作者
乙型肝炎病毒相关性肝细胞癌年轻患者行根治性切除术的预后因素:多中心研究
曾J,林K,刘辉等
癌症管理与研究| 2020年8月1日

鉴于有关年轻和年长肝细胞癌(HCC)患者预后的争论,研究人员试图比较年龄在≤40岁的年轻人与年龄在40岁以上的乙型肝炎病毒(HBV)相关的HCC患者根治性切除后的临床病理特征和预后。在4,504例接受根治性切除术的HBV相关性HCC患者中,年轻组699例,老年组3,805例。青年患者与老年患者表现出更好的肝功能,更具侵略性的肿瘤特征和更差的预后。在年轻患者中观察到OS和RFS差与肿瘤大小≥5 cm和大血管浸润相关。如果更频繁的监测可以在早期发现肿瘤,则可以预期年轻患者的长期生存。

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30441 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

3
发表于 2020-8-1 20:02 |只看该作者
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册

肝胆相照论坛

GMT+8, 2024-5-11 21:10 , Processed in 0.027609 second(s), 19 queries , Gzip On.

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.